Great Point Capital

Great Point Partners is a leading healthcare-focused private equity and hedge fund manager founded in 2003. It manages approximately $1.5–$1.7 billion across private and public funds, investing primarily in biopharmaceutical services, medical devices, contract manufacturing organizations (CDMOs), alternate site care providers, and information technology-enabled businesses within healthcare. Its BioMedical Value Fund invests in small/mid-cap public biotech and life sciences companies with innovative technologies to improve disease treatment and management. The firm has completed over 100 tuck-in acquisitions for its portfolio companies and has invested in more than 100 growing healthcare businesses across North America and Europe.